Clinical Trials
4 trialsNCT06199713 2026-01-20
Correlating Early FDG PET/CT and ctDNA in Immune Checkpoint Inhibitor (ICI)-Treated Melanoma Patients
University of Wisconsin, Madison
Recruiting
NCT02922283 2024-05-06
IL2 Imaging in Metastatic Melanoma
University Medical Center Groningen
Phase NA Terminated
NCT03089606 2023-11-15
Pembrolizumab TX-naive Distant Mets Melanoma and Use of (C11-AMT) PET at Baseline as Imaging Biomarker
UNC Lineberger Comprehensive Cancer Center
Phase 2 Completed
NCT02236546 2017-04-13
FDG-PET in Advanced Melanoma
Vanderbilt-Ingram Cancer Center
Phase NA Terminated